{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:03:40Z","timestamp":1771488220944,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["823019933"],"award-info":[{"award-number":["823019933"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04317-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:01:46Z","timestamp":1771484506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microwave ablation combined with dendritic cells enhances CD8+ T cell activation in rechallenged tumor mouse model"],"prefix":"10.1007","volume":"75","author":[{"given":"Ji","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengkuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiyang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"4317_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345","journal-title":"CA Cancer J Clin"},{"key":"4317_CR2","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP (2023) The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol 20:624\u2013639","journal-title":"Nat Rev Clin Oncol"},{"key":"4317_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, DeCamp M, Desai AP, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Lin J, Loo BW, Lovly CM, Maldonado F, Massarelli E, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patel SP, Patil T, Polanco PM, Riess J, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yang SC, Yau E, Gregory KM, Hang L (2024) Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22:249\u2013274","journal-title":"J Natl Compr Canc Netw"},{"key":"4317_CR4","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiol.2513081564","volume":"251","author":"CL Brace","year":"2009","unstructured":"Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT Jr. (2009) Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiol 251:705\u2013711","journal-title":"Radiol"},{"key":"4317_CR5","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1007\/s00330-022-08615-8","volume":"32","author":"Y Ni","year":"2022","unstructured":"Ni Y, Huang G, Yang X, Ye X, Li X, Feng Q, Li Y, Li W, Wang J, Han X, Meng M, Zou Z, Wei Z (2022) Microwave ablation treatment for medically inoperable stage I non-small cell lung cancers: long-term results. Eur Radiol 32:5616\u20135622","journal-title":"Eur Radiol"},{"key":"4317_CR6","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1007\/s00330-019-06613-x","volume":"30","author":"Z Wei","year":"2020","unstructured":"Wei Z, Yang X, Ye X, Feng Q, Xu Y, Zhang L, Sun W, Dong Y, Meng Q, Li T, Wang C, Li G, Zhang K, Li P, Bi J, Xue G, Sun Y, Sheng L, Liu B, Yu G, Ren H, Wang J, Sun L, Chen S, Geng D, Zhang B, Xu X, Zhang L, Sun D, Xu X, Diao C, Huang G, Li W, Han X, Wang J, Meng M, Ni Y, Zheng A, Fan W, Li Y, Li F, Fan H, Zou Z, Li Q, Tian H (2020) Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. Eur Radiol 30:2692\u20132702","journal-title":"Eur Radiol"},{"key":"4317_CR7","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.athoracsur.2018.10.049","volume":"107","author":"DB Nelson","year":"2019","unstructured":"Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WL (2019) Local recurrence after microwave ablation of lung malignancies: a systematic review. Ann Thorac Surg 107:1876\u20131883","journal-title":"Ann Thorac Surg"},{"key":"4317_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41571-024-00979-8","volume":"22","author":"Y Wang","year":"2025","unstructured":"Wang Y, Safi M, Hirsch FR, Lu S, Peters S, Govindan R, Rosell R, Park K, Zhang JJ (2025) Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions. Nat Rev Clin Oncol 22:200\u2013214","journal-title":"Nat Rev Clin Oncol"},{"key":"4317_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","volume":"23","author":"M O'Brien","year":"2022","unstructured":"O\u2019Brien M, Paz-Ares L, Marreaud S, Dafni U, Oselin K, Havel L, Esteban E, Isla D, Martinez-Marti A, Faehling M, Tsuboi M, Lee JS, Nakagawa K, Yang J, Samkari A, Keller SM, Mauer M, Jha N, Stahel R, Besse B, Peters S, E.-L.E.P.K.-. I (2022) Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. Lancet Oncol 23:1274\u20131286","journal-title":"Lancet Oncol"},{"key":"4317_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/cac2.12596","volume":"44","author":"J Chen","year":"2024","unstructured":"Chen J, Duan Y, Che J, Zhu J (2024) Dysfunction of dendritic cells in tumor microenvironment and immunotherapy. Cancer Commun Lond 44:1047\u20131070","journal-title":"Cancer Commun Lond"},{"key":"4317_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41577-018-0088-1","volume":"19","author":"SC Eisenbarth","year":"2019","unstructured":"Eisenbarth SC (2019) Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol 19:89\u2013103","journal-title":"Nat Rev Immunol"},{"key":"4317_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101848","volume":"71","author":"C Moussion","year":"2024","unstructured":"Moussion C, Delamarre L (2024) Antigen cross-presentation by dendritic cells: a critical axis in cancer immunotherapy. Semin Immunol 71:101848","journal-title":"Semin Immunol"},{"key":"4317_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1541105","volume":"16","author":"J Ma","year":"2025","unstructured":"Ma J, Wei Z, Ye X (2025) Interventional oncology and immunotherapy: current status and future perspectives. Front Immunol 16:1541105","journal-title":"Front Immunol"},{"key":"4317_CR14","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.2147\/JIR.S462650","volume":"17","author":"LP Sang","year":"2024","unstructured":"Sang LP, Wang JM et al (2024) Dynamic changes in the immune microenvironment in tumor-draining lymph nodes of a Lewis lung cancer mouse model after microwave ablation. J Inflamm Res 17:4175\u20134186","journal-title":"J Inflamm Res"},{"key":"4317_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, Kutach A, Joo W, Gao Z, Fu D, To C, Mondal K, Li B, Kekatpure A, Wang M, Laird T, Horner G, Chan J, McEntee M, Lopez M, Lakshminarasimhan D, White A, Wang SP, Yao J, Yie J, Matern H, Solloway M, Haldankar R, Parsons T, Tang J, Shen WD, Chen YA, Tian H, Allan BB (2017) Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550:255\u2013259","journal-title":"Nature"},{"key":"4317_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s43018-020-0036-4","volume":"1","author":"ME Hoekstra","year":"2020","unstructured":"Hoekstra ME, Bornes L, Dijkgraaf FE, Philips D, Pardieck IN, Toebes M, Thommen DS, van Rheenen J, Schumacher TNM (2020) Long-distance modulation of bystander tumor cells by CD8(+) T cell-secreted IFNgamma. Nat Cancer 1:291\u2013301","journal-title":"Nat Cancer"},{"key":"4317_CR17","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/JCI123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, Celis E, Abrams SI, Ozato K, Liu K (2018) An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest 128:5549\u20135560","journal-title":"J Clin Invest"},{"key":"4317_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304501","volume":"11","author":"Z Yang","year":"2024","unstructured":"Yang Z, Liu L, Zhu Z, Hu Z, Liu B, Gong J, Jin Y, Luo J, Deng Y, Jin Y, Wang G, Yin Y (2024) Tumor-associated monocytes reprogram CD8(+) T cells into central memory-like cells with potent antitumor effects. Adv Sci Weinh 11:e2304501","journal-title":"Adv Sci Weinh"},{"key":"4317_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-0716-2938-3_5","volume":"2618","author":"G Pasqual","year":"2023","unstructured":"Pasqual G, Chudnovskiy A, Victora GD (2023) Monitoring the interaction between dendritic cells and T cells in vivo with LIPSTIC. Methods Mol Biol 2618:71\u201380","journal-title":"Methods Mol Biol"},{"key":"4317_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113984","volume":"385","author":"J Zheng","year":"2025","unstructured":"Zheng J, Li X, He A, Zhang Y, Yang Y, Dang M, Li Q, Mou Y, Dong H (2025) In situ antigen-capture strategies for enhancing dendritic cell-mediated anti-tumor immunity. J Control Release 385:113984","journal-title":"J Control Release"},{"issue":"30","key":"4317_CR21","doi-asserted-by":"publisher","first-page":"e2023739118","DOI":"10.1073\/pnas.2023739118","volume":"118","author":"M Tekguc","year":"2021","unstructured":"Tekguc M, Wing JB, Osaki M, Long J, Sakaguchi S (2021) Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells. Proc Natl Acad Sci 118(30):e2023739118","journal-title":"Proc Natl Acad Sci"},{"key":"4317_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114655","volume":"43","author":"E Wakamatsu","year":"2024","unstructured":"Wakamatsu E, Machiyama H, Toyota H, Takeuchi A, Hashimoto R, Kozono H, Yokosuka T (2024) Indirect suppression of CD4 T cell activation through LAG-3-mediated trans-endocytosis of MHC class II. Cell Rep 43:114655","journal-title":"Cell Rep"},{"key":"4317_CR23","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ccell.2024.02.013","volume":"42","author":"JD Beck","year":"2024","unstructured":"Beck JD, Diken M, Suchan M, Streuber M, Diken E, Kolb L, Allnoch L, Vascotto F, Peters D, Beissert T, Akilli-Ozturk O, Tureci O, Kreiter S, Vormehr M, Sahin U (2024) Long-lasting mRNA-encoded interleukin-2 restores CD8(+) T cell neoantigen immunity in MHC class I-deficient cancers. Cancer Cell 42:568-582 e511","journal-title":"Cancer Cell"},{"key":"4317_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2015.08.068","volume":"163","author":"CP Day","year":"2015","unstructured":"Day CP, Merlino G, Van Dyke T (2015) Preclinical mouse cancer models: a maze of opportunities and challenges. Cell 163:39\u201353","journal-title":"Cell"},{"key":"4317_CR25","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/621324","volume":"2015","author":"A Kellar","year":"2015","unstructured":"Kellar A, Egan C, Morris D (2015) Preclinical murine models for lung cancer: clinical trial applications. BioMed Res Int 2015:621324","journal-title":"BioMed Res Int"},{"key":"4317_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000317","author":"Y Yang","year":"2020","unstructured":"Yang Y, Sun M, Yao W, Wang F, Li X, Wang W, Li J, Gao Z, Qiu L, You R, Yang C, Ba Q, Wang H (2020) Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2019-000317","journal-title":"J Immunother Cancer"},{"key":"4317_CR27","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1021\/acsnano.0c09120","volume":"15","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Gong N, Zhang D, Li J, Han X, Dou J, Huang J, Zhu K, Liang P, Liang XJ, Yu J (2021) Mannose-derived carbon dots amplify microwave ablation-induced antitumor immune responses by capturing and transferring \u201cdanger signals\u201d to dendritic cells. ACS Nano 15:2920\u20132932","journal-title":"ACS Nano"},{"key":"4317_CR28","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1182\/blood.V96.9.3029","volume":"96","author":"K Brasel","year":"2000","unstructured":"Brasel K, De Smedt T, Smith JL, Maliszewski CR (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96:3029\u20133039","journal-title":"Blood"},{"key":"4317_CR29","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.4049\/jimmunol.174.11.6592","volume":"174","author":"SH Naik","year":"2005","unstructured":"Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, Lahoud MH, O\u2019Keeffe M, Shao QX, Chen WF, Villadangos JA, Shortman K, Wu L (2005) Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J Immunol 174:6592\u20136597","journal-title":"J Immunol"},{"key":"4317_CR30","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331:1565\u20131570","journal-title":"Science"},{"key":"4317_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN (2020) CD8(+) t cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer 20:218\u2013232","journal-title":"Nat Rev Cancer"},{"key":"4317_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen DS, Mellman I (2017) Elements of cancer immunity and the cancer-immune set point. Nature 541:321\u2013330","journal-title":"Nature"},{"key":"4317_CR33","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1182\/blood-2008-12-192419","volume":"114","author":"CA Klebanoff","year":"2009","unstructured":"Klebanoff CA, Yu Z, Hwang LN, Palmer DC, Gattinoni L, Restifo NP (2009) Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination. Blood 114:1776\u20131783","journal-title":"Blood"},{"key":"4317_CR34","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1073\/pnas.0503726102","volume":"102","author":"CA Klebanoff","year":"2005","unstructured":"Klebanoff CA, Gattinoni L, Torabi-Parizi P, Kerstann K, Cardones AR, Finkelstein SE, Palmer DC, Antony PA, Hwang ST, Rosenberg SA, Waldmann TA, Restifo NP (2005) Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci U S A 102:9571\u20139576","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4317_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413181","author":"M Wang","year":"2024","unstructured":"Wang M, Sang J, Xu F, Wang S, Liu P, Ma J, Chen Z, Xie Q, Wei Z, Ye X (2024) Microwave ablation combined with Flt3L provokes tumor-specific memory CD8(+) T cells-mediated antitumor immunity in response to PD-1 blockade. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202413181","journal-title":"Adv Sci"},{"key":"4317_CR36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, Engblom C, Pfirschke C, Siwicki M, Gungabeesoon J, Freeman GJ, Warren SE, Ong S, Browning E, Twitty CG, Pierce RH, Le MH, Algazi AP, Daud AI, Pai SI, Zippelius A, Weissleder R, Pittet MJ (2018) Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-gamma and IL-12. Immunity 49:1148-1161 e1147","journal-title":"Immunity"},{"key":"4317_CR37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger S, Dai D, Horton B, Gajewski TF (2017) Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31:711-723 e714","journal-title":"Cancer Cell"},{"key":"4317_CR38","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.it.2023.10.005","volume":"44","author":"A Rigamonti","year":"2023","unstructured":"Rigamonti A, Villar J, Segura E (2023) Monocyte differentiation within tissues: a renewed outlook. Trends Immunol 44:999\u20131013","journal-title":"Trends Immunol"},{"key":"4317_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310","journal-title":"Immunity"},{"key":"4317_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09202-9","author":"H Tang","year":"2025","unstructured":"Tang H, Wei Z, Zheng B, Cai Y, Wu P, Wu L, Ma X, Chen Y, Su S, Xu J, Qiao Y, Zhang Y, Miao J, Yu Z, Zhao Y, Xia Z, Zhou R, Liu J, Guo J, Liu Z, Xie Q, Ginhoux F, Zhao L, Li X, Xia B, Wu H, Zhang Y, Zhou T (2025) Rescuing dendritic cell interstitial motility sustains antitumour immunity. Nature. https:\/\/doi.org\/10.1038\/s41586-025-09202-9","journal-title":"Nature"},{"key":"4317_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2006.04.017","volume":"25","author":"RS Allan","year":"2006","unstructured":"Allan RS, Waithman J, Bedoui S, Jones CM, Villadangos JA, Zhan Y, Lew AM, Shortman K, Heath WR, Carbone FR (2006) Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25:153\u2013162","journal-title":"Immunity"},{"key":"4317_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek SK, Cueto FJ, Mujal AM, Melero I, Krummel MF, Sancho D (2020) Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol 20:7\u201324","journal-title":"Nat Rev Immunol"},{"key":"4317_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-3083.2007.01927.x","volume":"65","author":"TB Hunter","year":"2007","unstructured":"Hunter TB, Alsarraj M, Gladue RP, Bedian V, Antonia SJ (2007) An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell\/lymph node cell model. Scand J Immunol 65:479\u2013486","journal-title":"Scand J Immunol"},{"key":"4317_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adq8843","volume":"9","author":"A Chudnovskiy","year":"2024","unstructured":"Chudnovskiy A, Castro TBR, Nakandakari-Higa S, Cui A, Lin CH, Sade-Feldman M, Phillips BK, Pae J, Mesin L, Bortolatto J, Schweitzer LD, Pasqual G, Lu LF, Hacohen N, Victora GD (2024) Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4(+) T cell response. Sci Immunol 9:eadq8843","journal-title":"Sci Immunol"},{"key":"4317_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo C, You Z, Shi H, Sun Y, Du X, Palacios G, Guy C, Yuan S, Chapman NM, Lim SA, Sun X, Saravia J, Rankin S, Dhungana Y, Chi H (2023) SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620:200\u2013208","journal-title":"Nature"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04317-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04317-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:03:15Z","timestamp":1771484595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04317-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4317"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04317-y","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Animal Ethics Committee of Shandong First Medical University & Shandong Academy of Medical Sciences (Approval No. NSFC: 2020\u2013497).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"82"}}